Biliary and duodenal drainage for reducing the radiotoxic risk of antineoplastic (131)I-hypericin in rat models

Necrosis targeting radiopharmaceutical (131)I-hypericin ((131)I-Hyp) has been studied for the therapy of solid malignancies. However, serious side effects may be caused by its unwanted radioactivity after being metabolized by the liver and excreted via bile in the digestive tract. Thus the aim of th...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Exp Biol Med (Maywood)
Asıl Yazarlar: Li, Yue, Jiang, Cuihua, Jiang, Xiao, Sun, Ziping, Cona, Marlein Miranda, Liu, Wei, Zhang, Jian, Ni, Yicheng
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2015
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4935340/
https://ncbi.nlm.nih.gov/pubmed/25956680
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1535370215584891
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller